June 2026

41 Articles

No Section

eGFR imbalance may confound DOAC-VKA comparisons in kidney transplant recipients

2 March 2026
Author(s): Yifan Jin, Zhicheng Huang, Lijun Zhang, Xin Gan

Dear Editor,

From algorithms to care: ten principles for responsible deployment of artificial intelligence in healthcare

4 February 2026
Author(s): Federico Cabitza, Walter Ricciardi, Gino Gerosa, Gian Franco Gensini, Serafina Valente

Dear Editor,

Clinical Insights

Bedside contrast-enhanced ultrasound: Clinical applications for internal medicine

23 March 2026
Author(s): Andrea Boccatonda, Carla Serra

Point-of-care ultrasound (POCUS) is widely used in Internal Medicine for rapid bedside assessment, but conventional modalities such as B-mode and Doppler provide limited information on tissue... more

Commentary

Sustained innovation in ATTR-CM - Twenty years of innovation in transthyretin amyloidosis

30 April 2026
Author(s): Philip N Hawkins

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease caused by relentless accumulation of ATTR amyloid in the heart [1]. The past 20 years has seen ATTR-CM evolve from a seemingly... more

Rethinking atrial fibrillation classification: Static labels in a dynamic disease

12 April 2026
Author(s): Koohyar Ahmadzadeh, Amir Askarinejad, Gregory Y.H. Lip

Atrial fibrillation (AF) remains the most common arrhythmia worldwide and a major contributor to mortality and morbidity from stroke and heart failure (HF). Despite growing recognition that AF... more

Integrating multi-omics and artificial intelligence in internal medicine: Opportunities for precision care

12 April 2026
Author(s): Giovanni Santacroce, Antonio Lo Bello, Marietta Iacucci, Antonio Di Sabatino

Modern Internal Medicine stands at a critical inflection point. The traditional disease-centred paradigm, built on clinical phenotypes, organ-based classifications, and population-level evidence, is... more

Expanding the stroke risk paradigm: Left atrial size as a trigger for preventive action

31 March 2026
Author(s): David Pakizer, David Školoudík

Stroke is a vascular disease that impacts the brain and is one of the leading causes of disability and death worldwide; notably, heart diseases contribute significantly to its development and risk.... more

Editorial

When more money does not mean more health- disparities in healthcare efficiency in OECD

25 March 2026
Author(s): Nicolas Garin, Jordi Rello

How to improve the efficiency of the healthcare system is vividly debated, as states facing increased competition for resources struggle to contain healthcare costs. The question is: how do we ensure... more

Internal Medicine Flashcard

A deceptive lung mass in a smoker man

11 March 2026
Author(s): Shashank Kumar, Mahismita Patro, Susama Patra

A 50-year-old man presented with cough, streaky haemoptysis and left-sided chest pain for two weeks. He was a heavy smoker with 30 pack-years of smoking history. Clinical examination showed decreased... more

A woman with fever, feet hypostesia and disseminated papules

9 March 2026
Author(s): Inês Pereira Amaral, Ivânia Soares, Joana Antunes

A previously healthy 75-year-old woman presented with a 3-day history of fever (39.3°C), distal paresthesias and hypoesthesia of both feet, and abrupt onset of disseminated erythematous papules with... more

Letter to the Editor

Bedside-oriented new risk stratification in acute pulmonary embolism: Implications and clinical utility of the 2026 ACC/AHA guidelines compared with the 2019 ESC guidelines

27 April 2026
Author(s): Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Koh Ono, Takeshi Kimura, on behalf of the COMMAND VTE Registry-2 Investigators

Recently, the American College of Cardiology (ACC) and American Heart Association (AHA) with scientific joint committees published the new clinical practice guidelines of acute pulmonary embolism (PE... more

Is there a clinical benefit of mechanical CPR in obesity? Author’s reply

20 April 2026
Author(s): Saurabh Sujanyal, Ivan Huespe, Aayushi Pareek, Devang Sanghavi, Nick Kelly

We thank Steffen et.al for their thoughtful and constructive comments regarding our study evaluating the use of mechanical versus manual CPR in obese patients with in-hospital cardiac arrest [1,2].... more

Time and transitions in cardiogenic shock: making the Cath lab–CICU–cardiac step-down pathway reliable

13 April 2026
Author(s): Lukasz Szarpak, Katarzyna Karczewska, Jacek Smereka

While the ImCU models described by Canetta et al. and Turcato et al. arise from Internal Medicine, their broader relevance to cardiology lies not in patient case-mix, but in the principle that... more

eGFR imbalance and DOAC-VKA comparisons in kidney transplant recipients. Author’s reply

13 April 2026
Author(s): Michele Rossi, Gregory Y.H. Lip

We thank Jin et al [1] for the comment on methodological considerations regarding our study [2]. The observation of a higher mean eGFR in the DOAC group after propensity score matching (PSM) deserves... more

Rethinking readmission prediction in multiple chronic conditions: Clinical utility over accuracy

12 February 2026
Author(s): Susana Garcia-Gutierrez, Amaia Pikatza, Anna Renom, Raul Quirós, Re-Pluris Working group

Hospital readmissions among patients with multiple chronic conditions (MCC) represent a persistent challenge in European healthcare systems, with rates approaching 20 % in Spain and similar figures... more

Cardiorenal anemia syndrome: Are we ready for paradigm shifts?

6 February 2026
Author(s): Michal Pruc, Lukasz Szarpak

To the Editor

Is there a clinical benefit of mechanical CPR in obesity?

2 February 2026
Author(s): Henning Johann Steffen, Ibrahim Akin, Tobias Schupp

We read with interest the article by Sujanyal et al. investigating the outcomes of LUCAS®-assisted versus manual cardiopulmonary resuscitation (CPR) in obese patients with in-hospital cardiac arrest... more

Unmeasured confounders in residual OSA: The roles of polypharmacy, loop gain, and weight trajectory

31 January 2026
Author(s): Linru Zhong, Xinhai Zhu

We read with interest the article by Vitacca et al. [1] In this retrospective cohort spanning ten years of cardiorespiratory monitoring (CRM), the authors assessed residual respiratory events (rAHI≥... more

Cerebral small vessel disease: a potential risk modifier for future guidelines on management of dyslipidaemias

22 January 2026
Author(s): Luca Bonanni

Cerebral small vessel disease (cSVD) is a highly prevalent and prognostically relevant condition in older adults, yet it is not specifically addressed in current dyslipidaemia management guidelines.... more

Use of continuous morphine infusions in end-of-life care in an internal medicine ward

16 January 2026
Author(s): Matilde Ribeiro-Coimbra, Maria Carolina-Carvalho, Frederico Luís-Batista, Paulo Reis-Pina

The use of continuous opioid infusions at the end of life remains a clinically and ethically sensitive area in acute hospital practice[1,2]. International recommendations emphasize that opioids are... more

Comparison of primary prevention strategy guided by SCORE2 versus coronary artery calcium scoring in a non-diabetic population

7 January 2026
Author(s): Anthony MATTA, Dorota FERRIERES, Pauline COUGOUL, Vanessa NADER, Didier Carrié, Vanina BONGARD, Jean FERRIERES

Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide [1]. The role of preventive medicine in reducing the burden of CVD tends to grow because prevention is better... more

Clinical incidents attended by the internal medicine on-call team at a tertiary care hospital

5 January 2026
Author(s): Victoria Lobo-Antuña, Laura Abenza-Barberá, Francesc Puchades-Gimeno, José Chordá-Ribelles, Sara Carrascosa-García

On-call duty is a cornerstone of hospital-based Internal Medicine, yet it remains one of the least quantified and most debated components of medical practice. Originally conceived to address... more

Survival outcomes with LUCAS-AssiSTED VS MANUal CPR in in-hospital cardiac arrest obese patients

3 January 2026
Author(s): Saurabh Sujanyal, Ivan Huespe, Aayushi Pareek, Devang Sanghavi, Nick Kelly

Obesity has emerged as a global health challenge, contributing not only to chronic disease but also to poorer outcomes in acute, high-acuity situations such as cardiac arrest. In the in-hospital... more

Methodological and generalizability considerations in the study of bleeding risk with rivaroxaban vs apixaban in older VTE patients

1 January 2026
Author(s): Fuli Liu, Yuanming Ba

We read with great interest the nationwide register-based cohort study by Roupe et al., recently published in the European Journal of Internal Medicine [1]. The authors should be commended for... more

Antiplatelet therapy in patients with stable coronary artery disease who require long-term oral anticoagulation

29 December 2025
Author(s): Laurent Fauchier, Mickael Guglieri, Arnaud Bisson, Thibault Lenormand, Gregory Y.H. Lip

Coronary artery disease (CAD) and atrial fibrillation (AF) and frequently coexist, with overlapping cardiovascular risk factors [1]. Oral anticoagulants (OACs) are indicated for AF-related stroke... more

Refining cardio-kidney-metabolic phenotyping to strengthen interpretation and clinical translation in atrial fibrillation

28 December 2025
Author(s): Qianqian Yang, Jiaqi Xu, Yu Qiu, Ke Chen, Xiangdong Yang

We read with great interest the article by Mei and colleagues, who investigated cardiovascular-kidney-metabolic (CKM) domains in a large European cohort of patients with atrial fibrillation (AF) and... more

Quality-of-life outcomes after sleeve gastrectomy versus Roux-en-Y gastric bypass: looking beyond mean differences

23 December 2025
Author(s): Adila Abdulla, Chao Li

We read with great interest the article by ’t Hart et al. reporting long-term quality of life (QoL) outcomes after sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in the SleeveBypass... more

Beyond systemic biomarkers: Future directions in understanding the inflammatory nexus of obstructive sleep apnea and atrial fibrillation

8 December 2025
Author(s): Qianhui Niu

We read with great interest the article by Hunt et al. entitled “Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation,”... more

Original Article

Morning urinary calcium/creatinine ratio as a sex-specific screening tool for detecting hypercalciuria in hypoparathyroidism

27 February 2026
Author(s): Christina M. Berr, Carmina T. Fuss, Karen Gronemeyer, Birgit Löhr, Christian H. Pfob, Thomas Pusl, Stefanie Hahner

Hypercalciuria is a relevant complication in patients with treated hypoparathyroidism. While hypercalciuria is usually estimated by 24-hour urinary calcium excretion (24hUCa), the calcium/creatinine... more

Peripheral ulcerative keratitis (PUK) in autoimmune diseases: a severe ocular manifestation not always associated with systemic disease activity

23 February 2026
Author(s): Laura Pelegrín, Olga Araújo, Gerard Espinosa, Ignasi Rodríguez-Pintó, Raimon Sanmartí, Andrés Ponce, Verónica Gómez-Caverzaschi, Fátima Raad, Jesús Cívico, Josep Torras-Sanvicens, Ramón Quintana, Alex Fonollosa, Luca Cantarini, Claudia Fabiani, Maite Sainz-de-la-Maza, José Hernández-Rodríguez

Peripheral ulcerative keratitis (PUK) is a rare and severe ocular manifestation frequently associated with systemic autoimmune diseases. This retrospective two-center observational study including... more

Assessing the proportion of patients with type 2 diabetes in tertiary care eligible for combination therapy with GLP-1 receptor agonist and SGLT2 inhibitors

23 February 2026
Author(s): Anders B. Jensen, Frida Renström, Michael Brändle

That almost half of the patients with type 2 diabetes in tertiary care were eligible for combination therapy with GLP-1 RA and SGLT2i highlight the potential negative impact of restricting access to... more

Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study

20 February 2026
Author(s): Bianca Clerici, Giovanni Casazza, Antonio Russo, Laura Massironi, Antonella Moreo, Viola Dadone, Simone Birocchi, Francesca Bursi, Andrea Bonelli, Paolo Mattiello, Francesca Casanova, Chiara Pisetta, Mariangela Scavone, Marco Guazzi, Cristina Giannatasio, Simona Pierini, Giancarlo Agnelli, Gian Marco Podda

Left atrial enlargement (LAE) is a cardiac structural abnormality linked to adverse cardiovascular events, including stroke. However, its independent prognostic role in patients without atrial... more

Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF

18 February 2026
Author(s): George Ntaios, Andreas Goette, Michael G. Palazzolo, Christian Ruff, Mark S. Link, Kenneth W. Mahaffey, Anthony P. Carnicelli, John Eikelboom, Christopher B. Granger, Manesh Patel, Lars Wallentin, Robert P. Giugliano

Background: We performed an individual patient data analysis of COMBINE AF to assess differences in 14 clinically relevant outcomes between patients with paroxysmal (PAF) vs. non-PAF.Methods: Cox-... more

MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?

18 February 2026
Author(s): Emma Diletta Stea, Francesco Pesce, Ighli di Bari, Rossana Franzin, Michele Rossini, Simona Simone, Fausta Piancone, Fabio Sallustio, Arianna De Palma, Maria Antonietta Grignano, Paola Pontrelli, Marilena Gregorini, Tefik Islami, Teresa Rampino, Giuseppe Castellano, Loreto Gesualdo

Immunoglobulin A nephropathy (IgAN) represents the most prevalent form of primary glomerulonephritis globally and constitutes a major contributor to the burden of end-stage renal disease (ESRD) [1].... more

The changing prognosis of infective endocarditis. A 15-year analysis

14 February 2026
Author(s): Manuel Martínez-Sellés, Patricia Muñoz, Maricela Valerio, María Carmen Fariñas, Aristides de Alarcón, Raquel Rodríguez-García, Miguel Ángel Goenaga-Sánchez, Ane Josune Goikoetxea, Guillermo Ojeda-Burgos, Elisa García-Vázquez, María Dolores Sousa-Regueiro, José M. Miró, Antonio Ramos-Martínez, Spanish Collaboration on Endocarditis - Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES)

Infective endocarditis (IE) mortality remains high. Population aging makes the aim of improving IE prognosis particularly difficult, as age is associated with comorbidity and mortality. Our objective... more

Genetic, and clinical features in Italian and lebanese subjects with familial mediterranean fever (FMF)

7 February 2026
Author(s): Nour Jaber, Mohamad Khalil, Hala Abdallah, Laura Mahdi, Vita Giordano, Ahmad Daher, Fatima Shamesseddin, Ghassan Ghssein, Nicoletta Resta, Agostino Di Ciaula, Alessandro Stella, Piero Portincasa

Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease with variable manifestations across Mediterranean regions. This study compares FMF cohorts from Italy (Apulia) and Lebanon... more

Review Article

How to monitor disease progression in ATTR amyloid cardiomyopathy: Implications for clinical practice and trial design

20 February 2026
Author(s): Aldostefano Porcari, Sarah AM Cuddy, Marco Metra, Michele Emdin, Marianna Fontana, Julian D Gillmore

Transthyretin amyloid cardiomyopathy (ATTR-CM) has been traditionally considered a rare and inexorably fatal condition. However, the development of therapies able to slow or halt ATTR-CM progression... more

Redefining optimal medical therapy for heart failure in amyloid transthyretin cardiomyopathy

14 February 2026
Author(s): Alberto Aimo, Michele Emdin, Giuseppe Vergaro, Julian D Gillmore, Marianna Fontana

Amyloid transthyretin cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy and an underdiagnosed cause of heart failure (HF) across the left ventricular ejection fraction spectrum. As disease-... more

Omics medicine: what the clinicians should know

10 February 2026
Author(s): Michela Gottardi Zamperla, Veronica Barbi, Sara Negri, Sandra Atlante, Carlo Gaetano

Omics technologies analyze comprehensive molecular datasets, enabling the detailed characterization of pathological processes. Genomic, transcriptomic, proteomic, and metabolomic approaches, as well... more

Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside

1 February 2026
Author(s): Silvia Malinverni, Giuseppe Vergaro, Guglielmo Verona, Aldostefano Porcari

Transthyretin (ATTR) amyloidosis is a multisystem disease caused by misfolding and aggregation of the plasma protein transthyretin (TTR) into insoluble amyloid fibrils in various organs [1]. This... more

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis

28 November 2025
Author(s): Aldostefano Porcari, Matteo Serenelli, Rossana Bussani, Gianfranco Sinagra, Lucia Venneri

Transthyretin amyloid cardiomyopathy (ATTR-CM) and aortic stenosis (AS) frequently coexist in elderly patients, particularly men, creating a complex clinical scenario with overlapping symptoms and... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness